Introduction
Pressure ulcers (PUs) are a frequent public health prob lem worldwide, growing prevalence as the population ages in recent years [1]. PUs are torturous, costly and negatively impacts the quality of life of the patient and their caregivers. There are more cases as life expectancy increases. Despite numerous measures used to prevent and cure pressure ulcers, either some cases are resist ant to treatment, or the healing process is slower than expected, prevalent among the elderly and critically ill patients [2]. Thus, effective management of PUs is crucial. CB-MNCs, harvested from neonatal umbilical cord blood, are composed mainly of lymphocytes and mono cytes, and are rich in various types of stem cells includ ing hematopoietic stem cells, endothelial progenitor cells, lymphoid progenitor cells, embryonic-like stem cells, and mesenchymal stem cells [3]. Due to their low immuno genicity, allogeneic CB-MNCs do not trigger an immune